Begin main content

Call for Patient Input: Dupixent

Published on: August 15, 2017
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.

Dupixent

Brand name Generic name Manufacturer Indication(s)
Dupixent dupilumab Sanofi-Genzyme atopic dermatitis
Project Number Call for patient input Patient input deadline Submit patient input
SR0533-000 2017-08-15 2017-10-04 Submit